Jun 26, 2023 / 03:00PM GMT
Operator
Good morning and welcome to the Eupraxia Phase 2b results conference call. (Operator Instructions) I will now turn the call over to Bruce Cousins, President and Chief Financial Officer of Eupraxia Pharmaceuticals. Please go ahead.
Bruce Cousins - Eupraxia Pharmaceuticals Inc. - President & CFO
Good morning, everyone, and thank you for joining us this morning. With me on the call today are Chief Executive Officer and Eupraxia Co-Founder, Dr. James Helliwell; Chief Scientific Officer and Co-Founder, Dr. Amanda Malone; our Chief Medical Officer, Dr. Mark Kowalski; and our Chief Business Officer, Paul Brennan. Following some prepared remarks, we will have a Q&A session. The operator will provide instructions on how to ask questions at that time.
Before I turn the call over to Dr. Helliwell, please note that statements made during this call, including answers to questions may include forward-looking statements regarding Eupraxia and its business strategy and objectives. This could include management's expectations around its product candidates and
Eupraxia Pharmaceuticals Inc To Discuss the Trial Results Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot